Navigation Links
A low prevalence of H pylori in HIV-positive patients
Date:10/16/2007

Helicobacter pylori has been extensively studied and proven to be the main cause of chronic gastritis and peptic ulcer in the HIV-negative population. Patients with chronic active gastritis have evidence of H pylori infection in over 90% of cases and in 70-100% of those with peptic ulcer disease. However, the reason for low incidence of H pylori infection in HIV-positive patients was still not very clear. A study examining this issue was recently reported in the November 7 issue of the World Journal of Gastroenterology because of its great significance for AIDS-related diseases.

The article describes 151 patients for gastrointestinal symptoms underwent endoscopic examination in Beijing Youan Hospital, Capital Medical University, the largest referral center for the management of HIV infection and HIV-related complications in China, from January 2003 to March 2006. The HIV-positive patients in the present study, mainly from HeNan province, were infected through illegal blood plasma collection.

One conclusion reported by the investigators is that patients with HIV infection have a low prevalence of H pylori infection and peptic ulcer than that of HIV-negative patients with similar symptoms. The mechanism of chronic active gastritis in HIV-positive patients may be different from HIV-negative group that was closely related to H pylori infection. Various opportunistic infections of Upper gastrointestinal tract is likely to occur in HIV-positive patients with a CD4 lymphocyte counts less than 200/muL, such as CMV infection, Candida esophagitis.

Another interesting conclusion is that 84 % of HIV-positive patients co-infected with HCV and/or HBV infection. Endoscopic examination also revealed findings such as esophago-gastric varices and portal hypertensive gastropathy that was significantly different from previous reports.

The results of this study suggest a different mechanism of peptic ulcerogenesis and a different role of H pylori infe
'/>"/>

Contact: You-De Chang
y.d.chang@wjgnet.com
0086-108-538-1892
World Journal of Gastroenterology
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. High Prevalence of AIDS among Indian Truck drivers
2. Survey Reveals Alarming Prevalence Rates of Diabetes among US Adolescents
3. HIV Prevalence In Ethiopian Women Greater Than National Average
4. Prevalence Of AIDS Goes Down In Illinois
5. HIV Prevalence in South Africa May be on Decline
6. Prevalence of Self-reported Snoring, Sleep-disordered Breathing in Military
7. Decrease in AIDS prevalence rate in Kenya
8. Prevalence of Celiac disease in children with type 1 diabetes
9. Prevalence of AIDS Cases in UAE is Low
10. When prevalence Makes for Disparity in AIDS Care
11. Thailand Approves Strategic Plan To Reduce HIV Prevalence Among Youth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2008)...y 21 /PRNewswire-FirstCall/ -- Aflac Incorporated,...presentation at the Sanford,C. Bernstein & Co., LL...nce,2008., President and Chief Financial Officer ...ted, and he is scheduled to make a presentation on...orated presentation, Mr.,Cloninger will discuss th...
(Date:5/21/2008)...d SILVER SPRING, Md., May 21 /PRNewswire-USNewswir... (ADAA),( http://www.adaa.org ) and The HealthCent... announced that ADAA will join,HealthCentral,s gro...and,health experts dedicated to helping people suf... advice and support they need to cope with the,con...
(Date:5/21/2008)...s 1st quarter profit, enhanced operations and new ...ELES, May 21 /PRNewswire-FirstCall/ -- InstaCare C...butor of at-home testing diagnostics,for the chron...eveloper of,patent-pending technologies for e-heal...s for the first quarter period-ended March 31, 200...
(Date:5/21/2008)... Adverse Events in TORCH Showed Frequency Highest ...ONTO and RESEARCH TRIANGLE PARK, N.C., May 21 /PRN...500/50 (fluticasone propionate and,salmeterol inha...er of,cardiovascular adverse events compared to ot...from the TOwards a Revolution in COPD Health,(TORC...
Breaking Medicine News(10 mins):Health News:Aflac Incorporated to Present at the Sanford C. Bernstein & Co., LLC Twenty-Fourth Annual Strategic Decisions Conference 2008 2Health News:The Anxiety Disorders Association of America and The HealthCentral Network Form Alliance to Develop New Online Resources for Anxiety Disorders 2Health News:The Anxiety Disorders Association of America and The HealthCentral Network Form Alliance to Develop New Online Resources for Anxiety Disorders 3Health News:InstaCare Corp. in Turnaround Reports 258% Revenues Increase in 1Q 2008 2Health News:InstaCare Corp. in Turnaround Reports 258% Revenues Increase in 1Q 2008 3Health News:InstaCare Corp. in Turnaround Reports 258% Revenues Increase in 1Q 2008 4Health News:InstaCare Corp. in Turnaround Reports 258% Revenues Increase in 1Q 2008 5Health News:Three-Year COPD Study Found No Increase in Cardiac Events With Advair(R) 500/50 2Health News:Three-Year COPD Study Found No Increase in Cardiac Events With Advair(R) 500/50 3
...es from the saliva may be the biomarkers that can ...eople. These biomarkers are called salivary trans...e researchers have been able to successfully predi... of ten people. The UCLA team has developed ways t...
...ems to be entrenched in the brain development of t... for Neurological Research, Buenos Aires, Argentin...y not be able to help but gamble. According to the...ecision making abilities of 11 spontaneous gambler...
...ith or without breast feeding, weight gain in the ...ty, says a current study. Babies who are raised on...om the first week after birth only. This weight ga...d to a strong tendency of becoming obese for life....
... waistline, along with the elevated levels of trig...nesis and cardiac problems for post menopausal wom...s to estimate the risk of cardiovascular mortalit...is. Atherogenesis is the process of plaques etc fo...
Other Medicine News:
(Date:5/21/2008)...RNewswire/ -- Alba Therapeutics Corporation,announ...ial were presented,in the Clinical Advances in Cel...(DDW) meeting in San Diego, California. Results of... study of larazotide acetate for the,prevention of...n celiac,subjects in remission(1) were presented b...
(Date:5/21/2008)...J., May 21 /- Genta,Incorpo...ltiple abstracts,featuring its lead oncology produ... the American Society of Clinical Oncology (ASCO) ...ts include the following:, -- Initial Phase 1 Cl... oral gallium-containing Compound. Poster # 5...
(Date:5/21/2008)...Fibrosis Patients Cough More Than 600 Times Per Da...NFIELD, N.J., May 21 /- PTC Therapeut...g that the quantification of cough,frequency may o...stic,fibrosis (CF). Cough is one of the most promi.... According to data presented today at the,2008 In...
(Date:5/21/2008)...sents OrBIT Study Results Comparing Percutaneous, ...py at the 2008 American Urological.../- Uroplasty, Inc. (Amex:,U...actures and markets,innovative proprietary product...highlighted results from the OrBIT trial of its Ur...
Breaking Medicine Technology:Alba Therapeutics Announces the Presentation of Results of a Phase IIa Clinical Trial for Larazotide Acetate for the Treatment of Celiac Disease at the Digestive Disease Week Conference 2Alba Therapeutics Announces the Presentation of Results of a Phase IIa Clinical Trial for Larazotide Acetate for the Treatment of Celiac Disease at the Digestive Disease Week Conference 3Alba Therapeutics Announces the Presentation of Results of a Phase IIa Clinical Trial for Larazotide Acetate for the Treatment of Celiac Disease at the Digestive Disease Week Conference 4Alba Therapeutics Announces the Presentation of Results of a Phase IIa Clinical Trial for Larazotide Acetate for the Treatment of Celiac Disease at the Digestive Disease Week Conference 5Genta Clinical Programs Featured in Multiple Abstracts at the Annual Meeting of the American Society of Clinical Oncology 2Genta Clinical Programs Featured in Multiple Abstracts at the Annual Meeting of the American Society of Clinical Oncology 3PTC Therapeutics Announces Data Supporting Cough Frequency as a New Outcome Measure in Evaluating Treatments for Cystic Fibrosis 2PTC Therapeutics Announces Data Supporting Cough Frequency as a New Outcome Measure in Evaluating Treatments for Cystic Fibrosis 3PTC Therapeutics Announces Data Supporting Cough Frequency as a New Outcome Measure in Evaluating Treatments for Cystic Fibrosis 4Uroplasty Highlights Clinical Results From a Study of the Urgent(R) PC Neuromodulation System 2Uroplasty Highlights Clinical Results From a Study of the Urgent(R) PC Neuromodulation System 3Connecticut Bioscience Achievement Awards Presented at CURE Annual Meeting 7656 1Connecticut Bioscience Achievement Awards Presented at CURE Annual Meeting 7656 2HHS Marks Expansion of 1200th Health Center Meeting Key Bush Goal 7652 1HHS Marks Expansion of 1200th Health Center Meeting Key Bush Goal 7652 2URAC Names Sensei for Weight Loss as a Finalist in First Ever Best Practices in Consumer Empowerment and Protection Awards 7648 1URAC Names Sensei for Weight Loss as a Finalist in First Ever Best Practices in Consumer Empowerment and Protection Awards 7648 2URAC Names Sensei for Weight Loss as a Finalist in First Ever Best Practices in Consumer Empowerment and Protection Awards 7648 3Newly HIV Infected Gay Men Select Other Infected Partners 7644 1Newly HIV Infected Gay Men Select Other Infected Partners 7644 2
...ination , , , , , PARSIPPANY, NJ,(May 21, 2007) ...ne besylate with the angiotensin receptor blocker,...ductions in,seated systolic and diastolic blood pr... data presented at the American Society,of Hyperte...ing and,Exposition (ASH 2007). The Phase III regi...
...HD Patients Nearly Triple That,of General Populati...ANAPOLIS, May 23, 2007 /PRNewswire-FirstCall/ -- D...R) (atomoxetine HCl),improved symptoms of Attentio...ts with comorbid alcohol abuse disorder, suggestin...Strattera in,patients with both disorders. Results...
Other Medicine Technology:Amlodipine and Olmesartan Study Results Released;Late Breaker,Presented at American Society of Hypertension Twenty-Second Annual,Scientific Meeting (ASH 2007) 2Amlodipine and Olmesartan Study Results Released;Late Breaker,Presented at American Society of Hypertension Twenty-Second Annual,Scientific Meeting (ASH 2007) 3Amlodipine and Olmesartan Study Results Released;Late Breaker,Presented at American Society of Hypertension Twenty-Second Annual,Scientific Meeting (ASH 2007) 4Study Suggests Strattera Improved ADHD Symptoms in Patients With,Comorbid Alcohol Abuse 2Study Suggests Strattera Improved ADHD Symptoms in Patients With,Comorbid Alcohol Abuse 3Study Suggests Strattera Improved ADHD Symptoms in Patients With,Comorbid Alcohol Abuse 4Study Suggests Strattera Improved ADHD Symptoms in Patients With,Comorbid Alcohol Abuse 5Study Suggests Strattera Improved ADHD Symptoms in Patients With,Comorbid Alcohol Abuse 6
Malaria Pf. Assay Range
An immunochromatographic test for detection of 4 species of Plasmodium antigen ( P. falciparum , P. vivax , P. malariae , P. ovale ) in whole blood.
192 Test HRP-II Enzyme Immunoassay for the presence of Plasmodium falciparum infection.
Malaria device / strip (3 line, PAN-pLDH, P.f.-HRP2)
Medicine Products: